|
4 min., 45 sec.
|
Programs
Latest program rundownComing up:
Latest Features:
May 17, 2013 | NPR ·
May 17, 2013 | NPR ·
May 17, 2013 | NPR ·
Latest program rundownComing up:
Latest Features:
May 18, 2013 | NPR ·
May 18, 2013 | NPR ·
May 18, 2013 | NPR ·
Latest Saturday rundownWE Saturday Feature
May 18, 2013 | NPR ·
Latest Sunday rundown
WE Sunday Feature
May 19, 2013 | NPR ·
Pfizer Inc
May 6, 2013 — Men still need a prescription for the diamond-shaped blue pills. But instead of going to the pharmacy in person, or taking their chances buying from an online pharmacy of unknown repute, men will be able to buy Viagra from the maker of the drug itself and have it shipped to their homes.
Comments |
Nov 7, 2012 — Xeljanz, a new rheumatoid arthritis drug, is the first one that works by blocking enzymes called janus kinases. They play a communication role inside the body and are involved in inflammation associated with rheumatoid arthritis.
Comments |
Aug 7, 2012 — Pfizer's research on an experimental drug that attacks plaques in the brain has been discontinued. But scientists say they're hopeful that new treatments that attack a specific protein in plaques will have better success.
Comments |
Jul 6, 2012 — Under an agreement between the drugmaker and the Center for Science in the Public Interest, Pfizer won't make claims about "breast health" or "colon health" for Centrum products. In return, the consumer group agreed not to take legal action.
Comments |
Feb 1, 2012 — Pfizer is recalling 1 million packages of oral contraceptives because of errors in the order or types of pills. The mistakes could leave women at risk for unintended pregnancy.
Comments |
Dec 1, 2011 — Two new generic brands of cholesterol-lowering medication threaten sales to Pfizer's number one selling drug — Lipitor. Good news? More people can afford it now.
Comments |


on:










